Immersion Corporation (NASDAQ:IMMR) income from continuing operations was $40.2 million for the year ended December 31, 2013 compared to a loss from continuing operations of $7.4 million for the year ended December 31, 2012. Immersion Corporation (NASDAQ:IMMR) shares after opening at $10.54 moved to $11.34 on last trade day and at the end of the day closed at $11.30. Company price to sales ratio in past twelve months was calculated as 6.70 and price to cash ratio as 4.47. Immersion Corporation (NASDAQ:IMMR) showed a positive weekly performance of 7.01%.
Johnson & Johnson‘s (NYSE:JNJ) Janssen Pharmaceuticals Inc. is hoping to gain approval for a new HIV treatment, a fixed-dose, once-daily antiretroviral drug that is being marketed as Prestiza in the U.S., according to a press release Tuesday. Johnson & Johnson (NYSE:JNJ) shares fell -0.30% in last trading session and ended the day on $97.94. JNJ return on equity ratio is recorded as 19.70% and its return on assets is 10.90%. Johnson & Johnson (NYSE:JNJ) yearly performance is 21.94%.
Biogen Idec Inc. (NASDAQ:BIIB) announced it will report first quarter 2014 financial results on Wednesday, April 23, 2014, before the financial markets open. Biogen Idec Inc. (NASDAQ:BIIB) shares moved up 1.28% in last trading session and was closed at $309.79, while trading in range of $305.31 – $316.34. Biogen Idec Inc. (NASDAQ:BIIB) year to date (YTD) performance is 10.81%.
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) reported a net loss of $69.4 million for the year ended December 31, 2013. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) weekly performance is -3.33%. On last trading day company shares ended up $9.88. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) distance from 50-day simple moving average (SMA50) is -31.78%. Analysts mean target price for the company is $20.43.